High Tower Advisors, LLC Catalyst Pharmaceuticals, Inc. Call Options Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
Call Options
3 transactions
Others Institutions Holding CPRX
# of Institutions
336Shares Held
95.5MCall Options Held
19.1KPut Options Held
51.1K-
Black Rock Inc. New York, NY18.7MShares$437 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.04MShares$188 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY6.23MShares$146 Million2.3% of portfolio
-
State Street Corp Boston, MA5.69MShares$133 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.02MShares$70.6 Million0.01% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.41B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...